Primary Peptides Inc is a clinical-stage biotech company based in Vancouver, Canada. We are developing novel peptide therapeutics using two platform technologies: 1) peptide array for identifying, targeting, and disrupting specific protein-protein interactions; 2) peptide-mediated protein knockdown technology that can replace antisense and siRNA technology platforms in many indications with greater specificity and greater temporal precision.